Zioptan
Product Images NDC 17478-609

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Zioptan (NDC 17478-609). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Akorn, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Zio00 0008 01

FDA Label Image

Zio00 0008 02

FDA Label Image

Zio00 0008 03

FDA Label Image

Zio00 0008 04

FDA Label Image

Zio00 0008 05

FDA Label Image

Zio00 0008 06

Zio00 0008 06
ZIOPTAN is an ophthalmic solution containing tafluprost at a concentration of 0.0015%. It is manufactured for Oak Pharmaceuticals Inc. and is only available with a prescription.*
FDA Label Image

Zio00 0008 07

Zio00 0008 07
ZIOPTAN® is a sterile ophthalmic solution for topical application in the eye. It is used for the treatment of high eye pressure associated with open-angle glaucoma or ocular hypertension. Each 0.3 mL single-use container contains 4.5 micrograms of the active ingredient tafluprost along with glycerol, sodium dihydrogen phosphate dihydrate, disodium edetate, polysorbate 80, and other inactive ingredients. It is refrigerated at 2° to 8°C (36° to 46°F) and should be discarded immediately after use. The solution is distributed by Akorn, Inc. and is manufactured for Oak Pharmaceuticals, Inc. and formulated in France. It is prescribed to be used once daily, in the evening, as one drop in the affected eye(s).*
FDA Label Image

Zio00 0008 08

Zio00 0008 08
ZIOPTAN® is a prescription drug used for topical application in eyes. It contains tafluprost ophthalmic solution to be stored refrigerated at 2° to 8°C. It is available in single-use containers for immediate use and contains active ingredients like Glycerol, Sodium Dihydrogen Phosphate Dihydrate, and others. Distributed by Akorn Inc. and Manufactured for Oak Pharmaceuticals, Inc. However, no indication or medical advice regarding its usage is provided in the given text.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.